Stock Updates

Today’s Top Gainers in the Market Sanofi (NYSE:SNY) from Healthcare

Today’s top gainers include the company Sanofi (NYSE:SNY) which is in the industry Drug Manufacturers – Major, gaining 1.02% today. In the last week its performance is -1.28%, and -9.93% for the past quarter. Currently, Sanofi, SNY has a target price of 51.67, so today’s gain of 1.02% is a significant step towards its target price. The GAP today is therefore 1.26%.

Sanofi (NYSE:SNY), has a market cap of 96654.45, and is based in France. Insider ownership is at 16.40%, and institutional ownership is 10.20%.

At the current price of 37.73, it has a dividend yield of 4.40%, and its target price is 51.67. This is with a profit margin of *TBA, and total debt/equity of *TBA. Sanofi (NYSE:SNY) has a P/E of 21.49, as well as a forward P/E of 12.73.

With a current EPS of 1.76, and a forecasted EPS growth for next year at -2.79%,Sanofi (NYSE:SNY) has had a EPS growth for the past five years at -4.40%. For the next five years EPS growth is projected to be 6.60%.

Performance for the year is -22.08%. Since its IPO date on 7/1/2002, the total performance to date is -7.81%.

Volume today for Sanofi (NYSE:SNY), is 3883400, while its average volume is 2259.96. Whilst the total gain today was 1.02%, it did have a day high of -7.07%.

Volatility for this week has been at 1.11%, and 1.17% for the month. The 52-week low for Sanofi, SNY has been 4.48%, while the 52-week-high has reached -24.22%.

Looking at its return of investments, which is 6.50%, and its return on assets is *TBA. Sanofi (NYSE:SNY) has an operating margin of *TBA. With a sales growth of *TBA quarter over quarter. Bearing in mind that Sanofi, SNY is in the sector Healthcare, its long-term debt/equity is *TBA, and has a current ratio of *TBA and *TBA for quick ratio.

So what is the value of Sanofi? Well its PEG is 3.26, and the P/S is 2.56, along with a P/B of 1.61. Meanwhile it has a p/cash of *TBA.

Disclaimer: Remember there is a risk to your investment, this is not a recommendation, nor personal advice, never invest more than you are able too loose.

About the author

Peter Clarke

Leave a Comment